Abstract: A nano drug delivery system includes a biofilm-coated drug nanocrystal. A drug in a physical form of nanocrystal is directly used as a rigid supporting skeleton, and is filled in a biofilm. The nano drug delivery system has the advantages of high drug loading capacity, good biocompatibility, long systemic circulation time and drug sustained release.
Type:
Grant
Filed:
March 30, 2018
Date of Patent:
March 1, 2022
Assignee:
Shanghai Whittlong Pharmaceutical Institute
Inventors:
Weiyue Lu, Zhilan Chai, Xuefeng Hu, Cao Xie, Huimin Hou, Hao Wang
Abstract: The present invention discloses a use of neohesperidin or a neohesperidin-containing plant extract in the manufacture of a product for improving and/or promoting skin microcirculation, or for eliminating and/or alleviating diseases or conditions associated with poor skin microcirculation. The present invention also discloses a composition comprising an effective amount of neohesperidin or a neohesperidin-containing plant extract, and to a method for improving and/or promoting skin microcirculation, or eliminating and/or alleviating diseases or conditions associated with poor skin microcirculation, by using neohesperidin. The skin microcirculation of the present invention is preferably eye skin microcirculation.
Type:
Grant
Filed:
May 9, 2019
Date of Patent:
March 1, 2022
Assignee:
NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD.
Abstract: Methods and apparatus for non-intrusive monitoring by sensing physical parameters such as electric and/or magnetic fields. Such apparatus and techniques may find application in a variety of fields, such as monitoring consumption of electricity, for example.
Type:
Grant
Filed:
October 14, 2016
Date of Patent:
March 1, 2022
Assignee:
Massachusetts Institute of Technology
Inventors:
John Sebastian Donnal, James Paris, Steven B. Leeb, David Lawrence
Abstract: Disclosed are compositions and methods useful for targeting and internalizing molecules into cells of interest and for penetration by molecules of tissues of interest. The compositions and methods are based on peptide sequences that are selectively internalized by a cell, penetrate tissue, or both. The disclosed internalization and tissue penetration is useful for delivering therapeutic and detectable agents to cells and tissues of interest.
Type:
Grant
Filed:
February 20, 2009
Date of Patent:
March 1, 2022
Assignee:
SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE
Inventors:
Erkki Ruoslahti, Tambet Teesalu, Kazuki Sugahara
Abstract: Disclosed is a system and method for remote sensing, surface profiling, object identification, and aiming based on two-photon population inversion and subsequent photon backscattering enhanced by superradiance using two co-propagating pump waves. The present disclosure enables efficient and highly-directional photon backscattering by generating the pump waves in properly pulsed time-frequency modes, proper spatial modes, with proper group-velocity difference in air. The pump waves are relatively delayed in a tunable pulse delay device and launched to free space along a desirable direction using a laser-pointing device. When the pump waves overlap in air, signal photons will be created through two-photon driven superradiant backscattering if target gas molecules are present. The backscattered signal photons propagate back, picked using optical filters, and detected.
Type:
Grant
Filed:
October 22, 2020
Date of Patent:
March 1, 2022
Assignee:
THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY
Abstract: The present disclosure relates to a plasma generator having a matching apparatus for matching impedances, and an impedance matching method. The plasma generator includes an RF power supply unit, a load device part including a standard load having a predetermined impedance and an antenna-plasma device configured to generate plasma, and a matching unit configured to connect the RF power supply unit to any one of the antenna-plasma device or the standard load, and match impedances of the RF power supply unit and the antenna-plasma device when the RF power supply unit is connected to the antenna-plasma device, wherein the matching unit is configured to detect a parasitic impedance according to parasitic components inside a circuit by connecting the standard load and the RF power supply unit, connect the antenna-plasma device, when the parasitic impedances are detected, calculate reactance required for the impedance matching, and change capacitance.
Abstract: A desiccant wheel is provided to be rotatable. Through the body of the wheel or a surface adsorbent, water vapor in humid air flow is adsorbed. By passing a high-temperature air flow through the wheel, the body or surface coating is regenerated with moisture removed. Along a cross-section radial, the wheel is divided into different areas. The body has three-dimensionally inter-connected pores. The pores can be of different types. The wheel is a complete concentric cylinder or a concentric cylinder comprising equal or unequal sectors. The equal or unequal sectors are separated with each other. The wheel can rotate at a fixed speed for continually repeating a process of adsorbing, transiting, and regenerating. Thereby, drying can be carried out without causing physical or chemical change to heat-sensitive material, which also improves drying efficiency, reduces size, lowers power consumption, and helps in carbon reduction for industry.
Type:
Grant
Filed:
December 11, 2019
Date of Patent:
March 1, 2022
Assignee:
Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C.
Inventors:
Heng Yi Li, Tsair-Fuh Huang, Sheng-Fu Yang, Po-Hsiu Kuo, Yu-Ren Chen, How-Ming Lee, To-Mei Wang
Abstract: Disclosed is a method of manufacturing a medium composition for cell culture, and a method of manufacturing a crushed stem cell extract using a method of manufacturing a medium composition for cell culture and a 3-low extracting method of active ingredients of a stem cell. The medium composition for cell culture includes a basal medium; a hyaluronic acid; and an additive composition. According to an embodiment, when active ingredients of a stem cell are extracted, a stem cell is crushed at a 3-low circumstance of low temperature, low pressure, a hypotonic circumstance.
Type:
Grant
Filed:
July 18, 2018
Date of Patent:
March 1, 2022
Assignee:
TIARA STEM CELL INSTITUTE
Inventors:
Young-Sil Kim, Jung-Eun Park, Hye-Jin Lee
Abstract: A phased-array includes, in part, N transceivers each including a receiver and a transmitter, and a controller. The phased array is configured to transmit a first radio signal from a first element of the array during a first time period, receive the first radio signal from a second element of the array, recover a first value associated with the radio signal received by the second element, transmit a second radio signal from the second element of the array during a second time period, receive the second radio signal from the first element of the array, recover a second value associated with the radio signal received by the first element, and determine a first phase of a reference signal received by the second element from the recovered first and second values. The first phase is relative to a second phase of the reference signal received by the first element.
Type:
Grant
Filed:
June 4, 2018
Date of Patent:
March 1, 2022
Assignee:
California Institute of Technology
Inventors:
Austin Fikes, Behrooz Abiri, Florian Bohn, Seyed Ali Hajimiri, Christopher Ian Walker, David Elliot Williams
Abstract: Technologies are provided for clockless physically unclonable functions (PUFs) in reconfigurable devices. Embodiments of the disclosed technologies include processing circuitry configured to perform numerous operations. The operations can include receiving a challenge continuous pulse signal, and generating a response continuous pulse signal by iteratively extending the challenge continuous pulse signal in time-domain. In some configurations, the iteratively extending includes generating a next continuous pulse signal by operating on a prior continuous pulse signal according to a stretching function, and generating a second next continuous pulse width signal by operating on the next continuous pulse signal according to a folding function.
Abstract: The present application discloses compounds which are activators of autophagic flux and pharmaceutical compositions comprising said activators. It further discloses use of said compounds and pharmaceutical compositions in the treatment of neurodegenerative diseases, particularly proteinopathies and tauopathies such as Alzheimer's disease. It further discloses methods of enhancing autophagic flux.
Type:
Grant
Filed:
March 13, 2020
Date of Patent:
March 1, 2022
Assignees:
The Trustees of Columbia University in the City of New York, NY State Psychiatric Institute
Inventors:
Kirsten Alison Rinderspacher, Wai Yu, Karen Duff, Donald Landry, Shi-Xian Deng
Abstract: An agent creating method of creating an agent in a game environment is provided. The agent creating method includes creating, by an agent creating apparatus, a base agent on the basis of a common action characteristic pattern of players to transfer the base agent to the game server, receiving, by the agent creating apparatus, match result data obtained by performing a match between the base agent and a character of an individual player, and performing, by the agent creating apparatus, machine learning by using the match result data and creating an evolved agent customized for matchmaking of the individual player on the basis of a result of the machine learning.
Type:
Grant
Filed:
December 9, 2019
Date of Patent:
March 1, 2022
Assignee:
Electronics and Telecommunications Research Institute
Abstract: The present invention is based, in part, on the identification of novel human anti-PD-1, PD-L1, and PD-L2 antibodies. Accordingly, the invention relates to compositions and methods for diagnosing, prognosing, and treating conditions that would benefit from modulating PD-1, PD-L1, and/or PD-L2 activity (e.g., persistent infections diseases, autoimmune diseases, asthma, transplant rejection, inflammatory disorders and tumors) using the novel human anti-PD-1, PD-L1, and PD-L2 antibodies described herein.
Type:
Grant
Filed:
July 9, 2019
Date of Patent:
March 1, 2022
Assignees:
DANA-FARBER CANCER INSTITUTE, INC., EMORY UNIVERSITY
Inventors:
Gordon J. Freeman, Rafi Ahmed, Timothy D. Jones, Francis J. Carr, James P. Gregson
Abstract: A block copolymer including a first block consisting of a polymer having a repeating structure of a structural unit (u1) containing no silicon atom, and a second block consisting of a polymer having a repeating structure of a structural unit (u2) containing a silicon atom, the second block containing a block (b21) consisting of a polymer having a repeating structure represented by general formula (u2-1), and a block (b22) consisting of a polymer having a repeating structure of a structural unit (u22) containing a silicon atom, and the block (b22) is positioned between the first block and the block (b21) (wherein RP211 represents an alkyl group, a halogenated alkyl group, a hydrogen atom, or an organic group having a polar group; and RP212 represents an organic group having a polar group).
Type:
Grant
Filed:
February 26, 2019
Date of Patent:
March 1, 2022
Assignees:
Tokyo Ohka Kogyo Co., Ltd., Tokyo Institute of Technology
Inventors:
Akiyoshi Yamazaki, Daisuke Kawana, Takehiro Seshimo, Teruaki Hayakawa, Lei Dong, Rin Odashima
Abstract: An impact resistant structure adapted to an electronic component. The impact resistant structure includes a resistance stack layer and a damping laminate. The resistance stack layer is disposed on a first surface of the electronic component, and the damping laminate is disposed on a second surface of the electronic component. The second surface of the electronic component is opposite to the first surface. The damping laminate includes a soft film and a support film, where the support film is disposed between the soft film and the electronic component.
Type:
Grant
Filed:
July 19, 2018
Date of Patent:
March 1, 2022
Assignees:
Industrial Technology Research Institute, Intellectual Property Innovation Corporation
Abstract: Disclosed are yeast cells expressing a polypeptide comprising a signal sequence and a human ApoE protein. In some embodiments the polypeptide comprises ApoE2. In some embodiments the polypeptide comprises ApoE3. In some embodiments the polypeptide comprises ApoE4. Also disclosed are methods of screening yeast cells to identify compounds that prevent or suppress Apo-induced toxicity. Compounds identified by such screens can be used to treat or prevent neurodegenerative disorders such as Alzheimer's disease. Also disclosed are methods of screening yeast cells to identify genetic suppressors or enhancers of ApoE-induced toxicity. Also disclosed are genetic suppressors or enhancers of ApoE-induced toxicity identified using the methods, and human homologs thereof. Also disclosed are methods of identifying compounds that modulate expression or activity of genetic modifiers of ApoE-induced toxicity.
Type:
Grant
Filed:
September 11, 2015
Date of Patent:
March 1, 2022
Assignee:
Whitehead Institute for Biomedical Research
Abstract: A system is disclosed and includes an electronic controller configured to generate a virtual reality representation of an environment. The electronic controller is configured to generate a menu within the virtual reality representation of the environment comprising at least one task user interface element and determine when an option for configuring a force parameter is selected from the at least one task user interface element in the menu. The electronic controller is configured to prompt a user to configure the force parameter for a virtual robot manipulation task and assign at least one of a force magnitude or a force direction to the virtual robot manipulation task in response to an input received from the prompt to configure the force parameter.
Abstract: Provided is a liquid crystal element. The liquid crystal element includes a first substrate, a first electrode provided on the first substrate, a liquid crystal layer provided on the first electrode and including a liquid crystal portion and a hydrophobic portion, and a second electrode on the liquid crystal layer, wherein the hydrophobic portion is phase-separated from the liquid crystal portion, wherein the liquid crystal portion includes polymer materials, a first dye, and liquid crystal molecules dispersed in the polymer materials, wherein the hydrophobic portion is spaced apart from the first electrode, wherein the hydrophobic portion includes hydrophobic materials and a second dye, wherein the first dye is dissolved in the polymer materials, wherein the second dye is dissolved in the hydrophobic portion, wherein the polymer materials include photo-curable polymer materials.
Type:
Grant
Filed:
June 30, 2020
Date of Patent:
March 1, 2022
Assignee:
Electronics and Telecommunications Research Institute
Inventors:
Gi Heon Kim, Won Jae Lee, Chi-Sun Hwang
Abstract: The present disclosure is directed, in some embodiments, to methods and compositions of comprising a cell having a non-internalizing receptor, and a nanoparticle surface-modified with a ligand that binds to the non-internalizing receptor.
Type:
Grant
Filed:
May 12, 2021
Date of Patent:
March 1, 2022
Assignee:
MASSACHUSETTS INSTITUTE OF TECHNOLOGY (MITN1)
Inventors:
Darrell J. Irvine, Yiran Zheng, Li Tang